Effect of phosphocreatine on patients treated by medical emergency teams
Official title: The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients: a Randomized Clinical Trial Protocol
Run by Università Vita-Salute San Raffaele · NCT06503016 · Data updated 2026-11-12
This study tests if giving phosphocreatine to hospitalized patients with serious conditions can help them recover faster and shorten their hospital stays compared to those who receive a placebo.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Università Vita-Salute San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | October 8, 2024 |
| Main results expected | April 2026 |
| Study ends | July 2026 |
| Registry record updated | August 6, 2025 |
| Trial ID | NCT06503016 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are hospitalized patients aged 18 and older with impending cardiac failure or other acute conditions requiring MET intervention.
✕Probably not a fit
Patients currently in the ICU or those with severe renal impairment or other critical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of phosphocreatine (PCr) on hospitalized patients who experience critical conditions requiring intervention from medical emergency teams. It is a multi-center, randomized, placebo-controlled phase 3 trial aimed at confirming the beneficial effects of PCr in reducing hospital stays and improving patient outcomes. The study focuses on patients with impending cardiac failure or other acute conditions that trigger MET activation. By comparing the outcomes of patients receiving PCr versus a placebo, the trial seeks to establish the efficacy of this natural energy-buffering molecule in enhancing recovery.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce hospital stays and improve survival rates for patients experiencing acute medical emergencies.
How similar studies have gone: Previous studies have indicated promising results for phosphocreatine in acute cardiac conditions, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Admitted in hospital (but outside ICU) 2. Age\>=18 years 3. Written informed consent 4. Serum creatinine \<=2 mg/dl 5. Patient with impending or underlying cardiac failure or cardiac arrest, irrespectively of the primitive organ failure, and the Medical Emergency Team (MET) is called upon at least one of the following: 1. Threatened airways; 2. Respiratory arrest; 3. Respiratory rate \<5 or \>36 breaths per min; 4. Pulse rate \<40 or \>140 beats per min; 5. Systolic blood pressure \< 90 mm Hg; 6. Sudden fall in level of consciousness; 7. Fall in Glasgow coma scale of \> 2 points. Exclusion Criteria: 1. Age \< 18 years; 2. Ongoing cardiac massage; 3. Current hospital admission from a care nursing facility; 4. Planned discharge to a care nursing facility; 5. Reasons for withdrawal of life-sustaining therapy; 6. History of kidney transplantation; 7. Solitary kidney (by any reason); 8. Serum Creatinine \> 2 mg/dl; 9. Immediate need for ICU admission; 10. Known allergy to PCr; 11. Pregnancy; 12. Previous enrollment and randomization into this trial; 13. Administration of PCr in the previous 30 day.
Where it's running
-
IRCCS San Raffaele Scientific Institute
Milan, Italy Recruiting
Study contacts
- Study coordinator: Giovanni Landoni, Prof.
- Email: landoni.giovanni@hsr.it
- Phone: +39022643
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
HeartBeam ECG Registry: See How Heartbeat Patterns Look Across People
This registry tests HeartBeam ECG recordings in real-world patients to build a de-identified database for research.
-
BIOTRONIK CSP Lead Registry for Left Bundle Branch Area Pacing
This registry tests BIOTRONIK’s CSP-based pacing lead in patients needing a pacemaker or CRT, to see how it performs in real-life use.
-
Platelet population changes during ECMO circulatory support
This will test whether the proportions of different platelet types change during ECMO in adults with cardiac or respiratory failure.
-
Dexmedetomidine versus dexamethasone added to ropivacaine for supraclavicular nerve block in upper‑limb surgery
This test compares two medicines added to ropivacaine to see which gives faster onset and longer pain relief for adults having upper‑limb surgery with an ultrasound‑guided supraclavicular nerve block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.